1 (Sirolimus 0.5 mg)
Pill with imprint 1 is Yellow, Round and has been identified as Sirolimus 0.5 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..
Sirolimus is used in the treatment of lymphangioleiomyomatosis; organ transplant, rejection prophylaxis and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. Risk cannot be ruled out during pregnancy. Sirolimus 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 1
Sirolimus
- Imprint:
- 1
- Strength:
- 0.5 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- MTOR inhibitors
Selective immunosuppressants - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Zydus Pharmaceuticals (USA) Inc.
- Inactive Ingredients:
-
- citric acid monohydrate
- crospovidone
- FD&C Yellow No. 5
- glyceryl monooleate
- hypromelloses
- ferric oxide yellow
- lactose monohydrate
- microcrystalline cellulose
- poloxamer 188
- polyethylene glycol
- povidone
- sucrose
- magnesium silicate
- titanium dioxide
- alpha tocopherol acetate
Note: Inactive ingredients may vary.
Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 68382-0520 | Zydus Pharmaceuticals (USA) Inc. |
| 68084-0956 | Amerisource Health Services |
More about sirolimus
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- Drug class: mTOR inhibitors
- FDA Alerts (2)
Consumer resources
Other brands: Rapamune
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
